Here is what I’m reading this morning in the world of healthcare:

• A lot of uncertainty on how Brexit will effect companies and this is a great example – AstraZeneca to stockpile drugs as Brexit ‘safety net’ (Reuters)
• With the advent of easily testing your DNA, people are finding that a DNA test can shatter your identity (The Atlantic)
• How are health insurers balancing the high price tag for CAR-T therapy with need? It depends on the payer. Most commercial insurers are covering CAR-T therapies now, but they do so on an individual basis, writing single-patient agreements each time, said cancer experts (MedCity News)
• Bill Gates Announces Further Investment In Alzheimer’s Research, Taking On Disease Detection (Forbes)